DICE Therapeutics
Eva Y. has extensive work experience in the pharmaceutical industry. Eva is currently the Director of Clinical Program and Operations Management at DICE Therapeutics. Prior to this, they held various roles at Genentech, including Senior Global Clinical Trial Leader, Global Clinical Trial Leader, Senior Clinical Trial Associate, and Country Clinical Operations Associate. Before joining Genentech, Eva worked as a Senior Associate in Global Regulatory Affairs and Safety Records at Amgen. Their career in the industry began as a Clinical Document Specialist at Genentech.
Eva Y. attended UC Berkeley Extension from 2007 to 2008 and completed the Clinical Trial Conduct and Management Certificate Program. At some point, Eva Y. also attended Appalachian State University, but the specific dates, degree, and field of study are unknown.
This person is not in any offices
DICE Therapeutics
At DICE Therapeutics, we design and develop innovative therapies in immunology for patients with debilitating disease. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, we are developing oral alternatives to medicines currently limited to injectable forms. We believe that such pills will be widely appreciated by patients and doctors alike, as they provide a lower bar to entry than biologics, and as oral medicines can easily be co-formulated with other efficacious drugs. The combination of our core technology with additional, unique biophysical insights has enabled DICE to target protein-protein interactions with small molecules. In doing so, DICE has cracked open a previously intractable set of clinically validated therapeutic targets, including Interleukin-17 (IL-17). Our lead program – an orally bioavailable IL-17 antagonist for the treatment of psoriasis – is currently progressing through IND-enabling studies. In parallel, we continue to advance both partnered and internal pipeline drug discovery programs, providing a robust pre-clinical pipeline.